	US 12,194,068 B2
	Dietary supplement composition for treating and managing acne
Jessica Maloh, Toronto (CA); Barbara A. Paldus, San Jose, CA (US); and Raja Sivamani, Sacramento, CA (US)
Assigned to CODEX LABS CORPORATION, San Jose, CA (US)
Filed by CODEX LABS CORPORATION, San Jose, CA (US)
Filed on Apr. 12, 2024, as Appl. No. 18/633,805.
Application 18/633,805 is a continuation of application No. 18/443,762, filed on Feb. 16, 2024.
Claims priority of provisional application 63/485,346, filed on Feb. 16, 2023.
Prior Publication US 2024/0277789 A1, Aug. 22, 2024
Int. Cl. A61K 35/747 (2015.01); A61K 9/00 (2006.01); A61K 31/353 (2006.01); A61K 31/57 (2006.01); A61K 35/00 (2006.01); A61K 35/742 (2015.01); A61K 35/745 (2015.01); A61K 36/328 (2006.01); A61K 36/82 (2006.01); A61K 45/06 (2006.01); A61P 17/10 (2006.01)

CPC A61K 35/747 (2013.01) [A61K 9/0053 (2013.01); A61K 31/353 (2013.01); A61K 31/57 (2013.01); A61K 35/742 (2013.01); A61K 35/745 (2013.01); A61K 36/328 (2013.01); A61K 36/82 (2013.01); A61K 45/06 (2013.01); A61P 17/10 (2018.01); A61K 2035/115 (2013.01)]

15 Claims

1. An orally administrable dietary supplement composition comprising a therapeutically effective amount of: (a) a probiotic blend of bacterial components containing at least: (i) from about 1 to about 20 billion CFU of Lactobacillus acidophilus, (ii) from about 1 to about 20 billion CFU of Bifidobacterium lactis, and (iii) from about 1 to about 20 billion CFU of Bacillus coagulans; and (b) from about 500 to about 750 mg of guggul containing from about 25 to about 75 mg guggulsterone; and (c) from about 750 to about 1000 mg of green tea leaf containing from about 200 to about 500 mg of epigallocatechin-3-gallate (EGCG), wherein all weights are based on the total dry weight of the composition.